Article metrics
PDF
Other content recommended for you
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
- Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
- SARS-CoV-2 challenge studies: ethics and risk minimisation
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- Review of COVID-19 vaccine subtypes, efficacy and geographical distributions
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Will vaccination refusal prolong the war on SARS-CoV-2?